Regarding the AML/BA-2 patient, the progression from de novo AML (b, without BCR::ABL1, red circle) to relapse (b, with BCR::ABL1, black circle) occurred without any significant changes in the gene expression profile. This evidence concerns the gene BCR and acute myeloid leukemia.